AccuStem Sciences, Inc.
ACUT
$0.28
-$0.04-12.50%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 20.60% | -4.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.63% | -0.37% | |||
| Operating Income | -28.63% | 0.37% | |||
| Income Before Tax | -28.63% | 0.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.63% | 0.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.63% | 0.37% | |||
| EBIT | -28.63% | 0.37% | |||
| EBITDA | -28.63% | 0.35% | |||
| EPS Basic | -28.51% | 0.40% | |||
| Normalized Basic EPS | -28.21% | 0.00% | |||
| EPS Diluted | -28.51% | 0.40% | |||
| Normalized Diluted EPS | -28.21% | 0.00% | |||
| Average Basic Shares Outstanding | 0.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||